Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 19 to 79

Single-shot nerve block with IV dexamethasone for rebound pain after shoulder surgery

Official title: Pain Management Protocol Optimization for Rebound Pain Prevention and Enhanced Recovery After Shoulder Surgery: A Randomized Noninferiority Trial of Intravenous Dexamethasone Combined With Single-Shot Versus Continuous Brachial Plexus Block

Run by Seoul National University Hospital · NCT07699744 · Data updated 2026-11-12

This trial tests whether giving a one-time shoulder nerve block plus an IV dexamethasone dose can prevent rebound pain after shoulder surgery.

More Pain, Postoperative trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages19 Years to 79 Years
SexAll
Enrollment92 (estimated)
SponsorSeoul National University Hospital
Academic / other
Locations1 site (Seoul, Jongno-gu)
StatusRecruiting
StartedAugust 25, 2026
Main results expectedJune 15, 2027
Study endsJuly 15, 2027
Registry record updatedSeptember 29, 2026
Trial IDNCT07699744 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 19–79 years scheduled for elective shoulder surgery with brachial plexus block and MAC.

Probably not a fit

Patients with contraindications to dexamethasone or local anesthetics, complex comorbidities, or higher BMI may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

A randomized approach compares a single-shot interscalene brachial plexus block combined with intravenous dexamethasone to manage post-surgical shoulder pain. The study focuses on patients undergoing elective shoulder procedures and aims to see if the combination reduces rebound pain when the block wears off, potentially avoiding the need for a continuous catheter. Methods include standard anesthesia with MAC and monitoring, plus the IV steroid given at the time of block. Outcomes consider pain levels, analgesic use, and recovery parameters. The intervention is designed to be simpler and less technically demanding than continuous nerve block approaches.

Why it matters

Potential benefit: If successful, patients may experience less rebound pain and rely less on ongoing catheter-based strategies.

How similar studies have gone: Previous strategies with nerve blocks and steroids have shown potential to extend analgesia; this exact IV steroid plus single-shot comparison represents a focused evaluation in this setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patients aged 19 to 79 years scheduled for elective shoulder surgery under brachial plexus block and monitored anesthesia care (MAC)

Exclusion Criteria:

* Pre-existing neurological deficit of the brachial plexus
* Emergency surgery
* American Society of Anesthesiologists (ASA) physical status classification IV or higher
* Contraindication or history of hypersensitivity to local anesthetics or dexamethasone
* Severe pulmonary disease (e.g., chronic obstructive pulmonary disease)
* Body mass index (BMI) ≥ 35 kg/m²
* Long-term use of steroids
* Long-term use of analgesics
* Inability to cooperate or communicate
* Pregnancy

Where it's running

  • Seoul National University Hospital
    Seoul, Jongno-gu, South Korea
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.